Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Lucherini
Everolimus, Lutetium-177 DOTATATE and Sunitinib for Advanced, Unresectable or Metastatic Neuroendocrine Tumours With Disease Progression: A Systematic Review and Cost-Effectiveness Analysis
Health Technology Assessment
Medicine
Health Policy
Related publications
PCN63 Cost-Effectiveness of Sunitinib in Patients With Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Imatinib for the Treatment of Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumours: Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
Matching Adjusted Indirect Comparison of Sunitinib and Everolimus for the Treatment of Pancreatic Neuroendocrine Tumours (PNETS)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Sunitinib Versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
International Journal of Technology Assessment in Health Care
Health Policy
Pazopanib Has Equivalent Anti-Tumor Effectiveness and Lower Total Costs Than Sunitinib for Treating Metastatic or Advanced Renal Cell Carcinoma: A Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Pcn165 - Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Radiofrequency Ablation for Unresectable Locally Advanced Pancreatic Cancer: A Systematic Review
HPB
Hepatology
Gastroenterology
The Clinical Effectiveness and Cost-Effectiveness of Enzyme Replacement Therapy for Gauchers Disease: A Systematic Review
Clinical Governance: An International Journal
Therapeutic Efficacy and Dosage of Pazopanib for Metastatic or Unresectable Advanced Soft Tissue Sarcomas
Chemotherapy: Open Access
